The Mayo Clinic and Xact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with ...

ALZpath, Inc. (ALZpath), a leading developer of diagnostic tools and solutions for Alzheimer's disease and related dementias, announced the addition of Samantha Budd Haeberlein, PhD, to its board of ...

biomarkers. Sample selection is critical and should rely on antemortem tissue from subjects that have postmortem confirmation of AD. Cerebrospinal fluid (CSF) is often used for AD studies because ...

Kiffik Biomedical, a leader in interstitial fluid (ISF)-based diagnostics, has announced a strategic partnership with Rubix ...

New research warns that blood tests for Alzheimer’s disease may be unreliable, particularly for Black patients. A recent ...

A study in Alzheimer's & Dementia has demonstrated the high accuracy of plasma p-tau217 as a blood-based biomarker for ...

An expert discusses how monitoring capillary leakage syndrome (CLS) requires vigilant assessment of fluid balance, hemodynamics, and biomarkers. Academic settings may have advanced resources, whereas ...

The New England-based firms said that they are developing a rapid at-home test that will be used to detect cancer biomarkers in interstitial fluid samples.

Medical researchers in Japan have discovered a way to predict a potentially life-threatening side effect of cancer immunotherapy before it occurs. By analyzing cerebrospinal fluid collected ...

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...

Reducing seven risk factors for heart disease and having higher Life's Simple 7 scores may help decrease biomarkers for ...